Literature DB >> 34847376

Microbial regulation of hexokinase 2 links mitochondrial metabolism and cell death in colitis.

Finn Hinrichsen1, Jacob Hamm1, Magdalena Westermann1, Lena Schröder1, Kensuke Shima2, Neha Mishra1, Alesia Walker3, Nina Sommer1, Kenneth Klischies1, Daniela Prasse4, Johannes Zimmermann5, Sina Kaiser1, Dora Bordoni1, Antonella Fazio1, Georgios Marinos5, Georg Laue1, Simon Imm1, Valentina Tremaroli6, Marijana Basic7, Robert Häsler8, Ruth A Schmitz4, Stefan Krautwald9, Andrea Wolf10, Bärbel Stecher11, Philippe Schmitt-Kopplin3, Christoph Kaleta5, Jan Rupp2, Fredrik Bäckhed12, Philip Rosenstiel1, Felix Sommer13.   

Abstract

Hexokinases (HK) catalyze the first step of glycolysis limiting its pace. HK2 is highly expressed in gut epithelium, contributes to immune responses, and is upregulated during inflammation. We examined the microbial regulation of HK2 and its impact on inflammation using mice lacking HK2 in intestinal epithelial cells (Hk2ΔIEC). Hk2ΔIEC mice were less susceptible to acute colitis. Analyzing the epithelial transcriptome from Hk2ΔIEC mice during colitis and using HK2-deficient intestinal organoids and Caco-2 cells revealed reduced mitochondrial respiration and epithelial cell death in the absence of HK2. The microbiota strongly regulated HK2 expression and activity. The microbially derived short-chain fatty acid (SCFA) butyrate repressed HK2 expression via histone deacetylase 8 (HDAC8) and reduced mitochondrial respiration in wild-type but not in HK2-deficient Caco-2 cells. Butyrate supplementation protected wild-type but not Hk2ΔIEC mice from colitis. Our findings define a mechanism how butyrate promotes intestinal homeostasis and suggest targeted HK2-inhibition as therapeutic avenue for inflammation.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HK2; butyrate; hexokinase; immunometabolism; inflammation; intestinal epithelial cell; microbiota

Mesh:

Substances:

Year:  2021        PMID: 34847376     DOI: 10.1016/j.cmet.2021.11.004

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  5 in total

Review 1.  The metabolic nature of inflammatory bowel diseases.

Authors:  Timon E Adolph; Moritz Meyer; Julian Schwärzler; Lisa Mayr; Felix Grabherr; Herbert Tilg
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-07-29       Impact factor: 73.082

2.  Mitochondrial Function and Microbial Metabolites as Central Regulators of Intestinal Immune Responses and Cancer.

Authors:  Saskia Weber-Stiehl; Lea Järke; Juan Camilo Castrillón-Betancur; Felix Gilbert; Felix Sommer
Journal:  Front Microbiol       Date:  2022-06-29       Impact factor: 6.064

Review 3.  Crosstalk Between the Gut Microbiota and Epithelial Cells Under Physiological and Infectious Conditions.

Authors:  An Zhou; Yi Yuan; Min Yang; Yujiao Huang; Xin Li; Shengpeng Li; Shiming Yang; Bo Tang
Journal:  Front Cell Infect Microbiol       Date:  2022-01-27       Impact factor: 5.293

4.  Lactobacillus paracasei BD5115-Derived 2-Hydroxy-3-Methylbutyric Acid Promotes Intestinal Epithelial Cells Proliferation by Upregulating the MYC Signaling Pathway.

Authors:  Zhenyi Qiao; Xiaohua Wang; Chaoyue Wang; Jin Han; Weiwei Qi; Huanchang Zhang; Zhenmin Liu; Chunping You
Journal:  Front Nutr       Date:  2022-03-17

Review 5.  Microenvironmental Metabolites in the Intestine: Messengers between Health and Disease.

Authors:  Antonio Enrico Zaurito; Markus Tschurtschenthaler
Journal:  Metabolites       Date:  2022-01-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.